The intestinal H+/peptide symporter PEPT1: structure-affinity relationships
- PMID: 14706811
- DOI: 10.1016/s0928-0987(03)00142-8
The intestinal H+/peptide symporter PEPT1: structure-affinity relationships
Abstract
Peptide transporter 1, PEPT1, of the mammalian enterocyte is presently under intense investigation in many laboratories because of its nutritional importance in the absorption of protein hydrolysis products and because more recent studies have shown that many drugs and prodrugs gain entry into the systemic circulation via PEPT1. Until the exact structural features of the substrate binding site of PEPT1 become available, for example by X-ray crystallography, determination of affinities followed by proof of actual membrane translocation will have to suffice when testing for possible new substrates for PEPT1. Affinity constants reflect the strength of their interaction with the binding site of the transporter. A review of the literature shows a wide range of affinity constants between 2 microM and 30 mM. We consider affinity constants for substrates or inhibitors of PEPT1 lower than 0.5 mM as high affinity, between 0.5 and 5.0 mM as medium affinity and above 5 mM as low affinity. Values above 15 mM we consider with great caution. In this mini-review we discuss affinities and structural determinants which affect affinities of a variety of substrates for PEPT1.
Similar articles
-
Modified amino acids and peptides as substrates for the intestinal peptide transporter PepT1.Eur J Biochem. 2000 Jun;267(12):3723-8. doi: 10.1046/j.1432-1327.2000.01405.x. Eur J Biochem. 2000. PMID: 10848990
-
Importance of a small N-terminal region in mammalian peptide transporters for substrate affinity and function.J Membr Biol. 2002 Mar 15;186(2):55-62. doi: 10.1007/s00232-001-0135-9. J Membr Biol. 2002. PMID: 11944083
-
Structural requirements for determining the substrate affinity of peptide transporters PEPT1 and PEPT2.Pflugers Arch. 2000 Sep;440(5):679-84. doi: 10.1007/s004240000339. Pflugers Arch. 2000. PMID: 11007306
-
Transport of drugs by proton-coupled peptide transporters: pearls and pitfalls.Expert Opin Drug Metab Toxicol. 2009 Aug;5(8):887-905. doi: 10.1517/17425250903042292. Expert Opin Drug Metab Toxicol. 2009. PMID: 19519280 Review.
-
Prodrug design targeting intestinal PepT1 for improved oral absorption: design and performance.Curr Drug Metab. 2013 Jul;14(6):675-87. doi: 10.2174/1389200211314060004. Curr Drug Metab. 2013. PMID: 23869811 Review.
Cited by
-
Evaluating Human Intestinal Cell Lines for Studying Dietary Protein Absorption.Nutrients. 2018 Mar 7;10(3):322. doi: 10.3390/nu10030322. Nutrients. 2018. PMID: 29518965 Free PMC article. Review.
-
Evidence of D-phenylglycine as delivering tool for improving L-dopa absorption.J Biomed Sci. 2010 Sep 6;17(1):71. doi: 10.1186/1423-0127-17-71. J Biomed Sci. 2010. PMID: 20815935 Free PMC article.
-
The proton-coupled amino acid transporter, SLC36A1 (hPAT1), transports Gly-Gly, Gly-Sar and other Gly-Gly mimetics.Br J Pharmacol. 2010 Oct;161(3):589-600. doi: 10.1111/j.1476-5381.2010.00888.x. Br J Pharmacol. 2010. PMID: 20880398 Free PMC article.
-
In vitro and pharmacophore-based discovery of novel hPEPT1 inhibitors.Pharm Res. 2005 Apr;22(4):512-7. doi: 10.1007/s11095-005-2505-y. Epub 2005 Apr 7. Pharm Res. 2005. PMID: 15846457
-
Engineering and functional characterization of a proton-driven β-lactam antibiotic translocation module for bionanotechnological applications.Sci Rep. 2021 Aug 26;11(1):17205. doi: 10.1038/s41598-021-96298-4. Sci Rep. 2021. PMID: 34446740 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources